daphnoretin and Fibrosis

daphnoretin has been researched along with Fibrosis* in 1 studies

Other Studies

1 other study(ies) available for daphnoretin and Fibrosis

Article	Year
Discovery of a coumarin derivative as Nrf2 activator mitigating oxidative stress and fibrosis in mesangial cells under high glucose. Bioorganic & medicinal chemistry letters, 2020, 10-15, Volume: 30, Issue:20 Diabetic nephropathy (DN) is a severe microvascular complication of diabetes mellitus. Oxidative stress and fibrosis largely contribute to the progression of DN. Recently, Nrf2 was found to be a potential target preventing DN. In the discovery of novel Nrf2 activators for the treatment of DN, we have evaluated coumarin derivatives from Wikstroemi indiaca. Molecular docking results have shown compound 4 could bind to Keap1 and activate Nrf2 significantly. Cell-based assays have revealed compound 4 activated Nrf2 and attenuated oxidative stress and fibrosis induced by high glucose in mesangial cells. Meanwhile, it was validated that disruption of the interaction between Keap1 and Nrf2 was involved in the activation of Nrf2 by compound 4 in mesangial cells under high glucose. Topics: Cell Proliferation; Cell Survival; Coumarins; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Discovery; Fibrosis; Glucose; Humans; Mesangial Cells; Molecular Docking Simulation; Molecular Structure; NF-E2-Related Factor 2; Oxidative Stress; Structure-Activity Relationship	2020

Article

Year

Discovery of a coumarin derivative as Nrf2 activator mitigating oxidative stress and fibrosis in mesangial cells under high glucose.

Bioorganic & medicinal chemistry letters, 2020, 10-15, Volume: 30, Issue:20

Diabetic nephropathy (DN) is a severe microvascular complication of diabetes mellitus. Oxidative stress and fibrosis largely contribute to the progression of DN. Recently, Nrf2 was found to be a potential target preventing DN. In the discovery of novel Nrf2 activators for the treatment of DN, we have evaluated coumarin derivatives from Wikstroemi indiaca. Molecular docking results have shown compound 4 could bind to Keap1 and activate Nrf2 significantly. Cell-based assays have revealed compound 4 activated Nrf2 and attenuated oxidative stress and fibrosis induced by high glucose in mesangial cells. Meanwhile, it was validated that disruption of the interaction between Keap1 and Nrf2 was involved in the activation of Nrf2 by compound 4 in mesangial cells under high glucose.

Topics: Cell Proliferation; Cell Survival; Coumarins; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Discovery; Fibrosis; Glucose; Humans; Mesangial Cells; Molecular Docking Simulation; Molecular Structure; NF-E2-Related Factor 2; Oxidative Stress; Structure-Activity Relationship

2020